In a report released today, Jeffrey Hung from Morgan Stanley maintained a Buy rating on Disc Medicine (IRON – Research Report), with a price target of $85.00. The company’s shares closed yesterday at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback